DAVITA INC. DL -,001/ US23918K1088 /
30/12/2024 13:56:10 | Chg. -1.700 | Volume | Bid30/12/2024 | Demandez à30/12/2024 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
147.150EUR | -1.14% | 6 Chiffrre d'affaires: 886.900 |
145.850Bid taille: 76 | 147.150Ask la taille: 76 | 11.83 Mrd.EUR | - | - |
GlobeNewswire
24/06
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salo...
Newsfile Corp
18/06
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
26/04
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
17/11/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
15/08/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
21/03/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
07/03/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
10/02/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
07/10/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
01/10/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page